Faculty Bibliography

BACKGROUND: Nightmares and insomnia in PTSD are hallmark symptoms, yet poorly understood in comparison to the advances toward a biological framework for the disorder. According to polysomnography (PSG), only minor changes in sleep architecture were described. This warrants alternative methods for assessing sleep regulation in PTSD. METHODS: After screening for obstructive sleep apnea and period limb movement disorder, veterans with PTSD (n=13), trauma controls (TCs, n=17) and healthy controls (HCs, n=15) slept in our sleep laboratory on two consecutive nights with an IV catheter out of which blood was sampled every 20min from 22:00h to 08:00h. Nocturnal levels of plasma adrenocorticotropic hormone (ACTH), cortisol, melatonin were assessed in conjunction with PSG registration, as well as subjective sleep parameters. RESULTS: PTSD patients showed a significant increase in awakenings during sleep in comparison to both control groups. These awakenings were correlated with ACTH levels during the night, and with the subjective perception of sleep depth. Also, heart rate (HR) was significantly increased in PTSD patients as compared with both control groups. The diurnal regulation of ACTH, cortisol and melatonin appeared undisturbed. PTSD patients exhibited lower cortisol levels at borderline significance (p=0.056) during the first half of the night. ACTH levels and cortisol levels during the first half of the night were inversely related to slow wave sleep (SWS). CONCLUSION: This study suggests that hypothalamo-pituitary-adrenal (HPA) axis activity is related to sleep fragmentation in PTSD. Also, activity of the sympathetic nervous system (SNS) is increased during sleep in PTSD. Further research is necessary to explore the potential causal relationship between sleep problems and the activity of the HPA-axis and SNS in PTSD.

Although the symptoms of Post-Traumatic Stress Disorder (PTSD) in the general and military population seem very similar, combat-related PTSD (cr-PTSD) is typically thought to be more severe due to the repeated and prolonged exposure of traumatic events. Therapeutic adherence is reported a problem in military populations compromising treatment efficacy. Therefore, a new potential supplementary treatment is specially designed for patients with cr-PTSD. This intervention is called Military Motion Memory Desensitization and Reprocessing (3MDR). The treatment incorporates key elements of successful treatments as Virtual Reality Exposure (VRE) and Eye Movement Desensitization Reprocessing (EMDR) and adds motion to the condition. We aimed at designing a treatment procedure that preserved dual task processing principle, yet introduced new engagement by performing the desensitization during motion by to walking on a treadmill. Moreover, we aimed at exposure to real high-affect pictures of deployment setting. Subjects walk a repetitive cycle while walking and viewing high affect pictures of deployment scenes. Dual task processing was maintained by an oscillating ball. Aspects of presence are adhered to, to maximize possible positive outcome. METHOD: Two veterans with chronic PTSD, received four weekly sessions of 3MDR therapy. The indicator of effectiveness was difference in CAPS (Clinical Administrated PTSD Scale)-score. The treatment was designed on the Computer Assisted Rehabilitation Environment (CAREN) facility. RESULTS: The 3MDR treatment did further decrease PTSD symptoms. Patients were highly satisfied about the treatment and had no attention to drop out. CONCLUSION: The results of the two cases suggest that the 3MDR treatment is a successful, more additional treatment that goes further into the patients affect where other treatment may stagnate. The presence was highly appreciated. Further research with more patients needs to be performed to obtain more reliable results.

One of the goals in research in the clinical neuroscience of trauma-related disorders is to apply findings related to the effects of traumatic stress in the brain on animals and patients with trauma and stressor-related disorders e.g. PTSD. The paradigm of translational neuroscience has been an avenue that has contributed much to a model of the neural circuitry of PTSD that is currently used in studies. In general, the neural circuits and systems mediating symptoms of all PTSD, trauma and stressor-related disorders can be studied by registering en assessing behavioral and biochemical responses to environmental/pharmacological challenge to specific neurochemical systems measuring neurotransmitters and hormone levels in blood, urine, and saliva; measuring key brain structures with neuroimaging (Magnetic Resonance Imaging, MRI), provoking disease-specific symptoms in conjunction with (functional) neuroimaging (functional MKT, fMRI), or using imaging (Positron Emission Tomography, PET) to measure neuroreceptors. The findings of the studies (research designs, methodologies, and some of the techniques) will be discussed in this chapter varying to a great extent. Three key mechanisms seen in PTSD are: stress sensitization, fear conditioning and failure of extinction. This chapter thither focuses on the functional neuroimaging research conducted in PTSD. It covers various techniques (SPECT, PET and fMRI) that are used in different kinds of paradigms (resting, active tasks and stimulus presentation) and provides a global overview of the brain circuits that currently, are used to explain the phenomenology in PTSD. The disorder showed remarkable heterogeneity in some recent studies. These give consideration to speculate on two models for the disorder that can alternate and coexist together. These two models will be presented, one, in which the amygdala is hyperactive, in line with fear circuitry, being the most common and dominant situation. In another model the amygdala is hypoactive, in line with predominance of symptoms of derealisation and depersonalization symptoms that are accompanying the other PTSD symptoms. Finally, the need for longitudinal studies is emphasized. Studies that assess patients before as well as after treatment are the paradigm that will be new and promising.